Our Objectives

TRANSFORM aims to facilitate discussions between stakeholders and policy-makers, with the following objectives:

  • Collaborate in the development and dissemination of evidence-based recommendations to enable patient access to cell and gene therapies.
  • Inform MEPs about the specificities of these transformative therapies with a view to shaping policy.
  • Prepare healthcare systems for the adoption of these transformative therapies.

@TRANSFORM_CGT on Twitter Follow us →

🧬Great panel discussion at Day 2 #ECRD2022 on ensuring health systems are ready for #innovation like #ATMPs, incl best practice examples & policy ideas Future-proofing the EU for transformative therapies is core to TRANSFORM's policy asks 👉https://t.co/gtuDl2L8Be
28 June at 2:19pm
RT @ipopi_info: Today is #InternationalNeonatalScreeningDay! Stay tuned all day to hear more about what INSD is, why it was created & why #…
28 June at 11:37am
RT @eurordis: Halfway through the opening session, @yann_eurordis praises the efforts of @EU_Commission but points out that "without a cohe…
28 June at 8:57am